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Abstract The primary goal of this study was to examine
environmental and neuroendocrine factors that convey
increased risk for elevated autistic behavior in boys with
Fragile X syndrome (FXS). This study involves three related
analyses: (1) examination of multiple dimensions of social
approach behaviors and how they vary over time, (2)
investigation of mean levels and modulation of salivary
cortisol levels in response to social interaction, and (3)
examination of the relationship of social approach and
autistic behaviors to salivary cortisol. Poor social approach
and elevated baseline and regulation cortisol are discernible
traits that distinguish boys with FXS and ASD from boys
with FXS only and from typically developing boys. In
addition, blunted cortisol change is associatedwithincreased
severity of autistic behaviors only within the FXS and ASD
group. Boys with FXS and ASD have distinct behavioral and
neuroendocrine profiles that differentiate them from those
with FXS alone and typically developing boys.
Keywords FragileX.Socialanxiety.Autism.
Socialapproach.Cortisol
Introduction
Fragile X syndrome (FXS) is the most prevalent form of
inherited intellectual disability, affecting approximately
1:4,000 males and 1:8,000 females [1]. This single gene
disorder is linked to the expansion of a CGG polymorphism
in the (5′UTR) regulatory region of the FMR1 gene.
Individuals with the full mutation (>200 vs. a normal range
of 5–40 CGG repeats) typically have hypermethylation of the
FMR1’s promoter, resulting in transcriptional silencing of the
gene and virtual absence of the Fragile X Mental Retardation
Protein (FMRP) [2]. FMRP is a widely expressed RNA-
binding protein that regulates protein synthesis at synaptic
sites [3, 4]. Magnitude of FMRP deficit correlates with
overall severity of physical and neurobehavioral phenotype
[5–7], but not consistently with selective behavioral abnor-
malities such as autistic behavior [8, 9]. Most males with
FXS tend to have mild to moderate intellectual disability,
characterized by variable cognitive and language impair-
ments, and associated neurobehavioral problems [2, 10].
Among the most frequent and severe behavioral abnor-
malities present throughout the spectrum of impairment in
FXS are disturbances in social interaction including
extreme shyness, social withdrawal, social avoidance,
social anxiety, and autism spectrum disorder (ASD)
[11–14]. Of these social abnormalities, only ASD has been
systematically studied in FXS. There is general agreement
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criteria for autistic disorder. Recent studies using the Autism
Diagnostic Observation Scale-Generic (ADOS-G) [15]o r
the Autism Diagnostic Interview–Revised [16] reflect an
increase in prevalence estimates with 25% to 50% of males
with FXS now described as meeting criteria for autism and
67% to 74% meeting criteria for the ASD [9, 13, 17–19].
SeveralstudieshavefocusedondifferentaspectsofASDin
FXS, demonstrating in relationship with non-autistic FXS
counterparts: lower IQ [12, 20–22], poorer adaptive behavior
skills [12, 23], and greater receptive language delays [17,
22]. Recently, there has been increased interest in studying a
continuum of autistic behaviors and in identifying specific
behaviors that differentiate autism in FXS from the broad
phenotype or other related disorders such as social anxiety.
This work has shown that poor eye contact and social
avoidance in initial social encounters, particularly in less
familiar settings [24]; self-injurious and compulsive behaviors
[19]; and low adaptability [25] are pervasive in FXS and are
not specific to those who have co-morbid ASD diagnoses. In
contrast, poor eye contact and social avoidance after sustained
interaction with people [24], social indifference and passive
social avoidance [14, 26], and severe deficits in non-verbal
social behaviors and withdrawn behavior [12, 13, 26, 27]
appear to be unique to individuals with FXS and ASD.
Abnormal activation of the hypothalamic-pituitary-
adrenal (HPA) axis is cited as one of the primary correlates
of social and emotional dysfunction in FXS [28]. The HPA
axis responds to and regulates stress by secretion of
corticotropin releasing hormone, which stimulates the
secretion of ACTH by the pituitary gland, leading to
release of cortisol by the adrenal glands [29]. Initial studies
reported elevated diurnal salivary cortisol levels and hyper-
reactivity in response to challenge in males with FXS
compared to their unaffected siblings [30, 31]. Subsequent
studies focused on more discrete time points related to
social challenge demonstrated elevated cortisol for
pre-challenge conditions, but similar cortisol levels for
post-challenge and reactivity (subtracting cortisol level
prior to challenge from cortisol during challenge) in males
with FXS compared to unaffected siblings [27]. Inconsis-
tent relationships between cortisol and problem behavior in
FXS have been reported. In an early study, a relationship
between a diurnal cortisol composite and the Total score
and Withdrawn subscale of the Child Behavior Checklist
(CBCL) [32] were reported [31]. However, subsequent
work using a more discrete measure of cortisol collected
during a pre-challenge condition was not related to any
CBCL composite or subscales [27]. Consistent across
multiple studies is a relationship between elevated pre-
challenge cortisol levels and autistic behaviors including
increased gaze avoidance during a social challenge [19, 27]
and higher total scores on the ADOS-G [19]. Additionally,
one study reported a relationship between suppressed
cortisol reactivity to a social challenge and increased gaze
avoidance [27].
Taken together, this work indicates that environmental
factors including setting, length of interaction, and stress
associated with social interaction or challenge is associated
withautisticbehaviorinFXSandthatabnormalHPAfunction
may contribute to the presence and severity of autistic
behavior inFXS. Identificationof the underlying mechanisms
and environmental presses that convey increased risk for
autistic behavior in FXS is critical to facilitate accurate
diagnoses as well as to develop interventions including
pharmacological agents, behavioral treatments, and environ-
mental modification(s).
To date, no study has examined the social approach
behaviors in males with FXS compared to a non-familial
typically developing comparison group using a dynamic
observational measure that includes multiple scales over
time. Also, only one study has been published that reported
pre-challenge, challenge, and reactivity conditions to
examine discrete cortisol levels across groups. However,
their measure was taken mid-day after the participants had
undergone various assessments that morning. Therefore,
while it was taken just before their social challenge, the
authors note that cortisol elevations that occurred earlier in
the day could have limited the pre-challenge cortisol
response [27]. The overarching purpose of the present
study is to examine environmental and neuroendocrine
determinants of autistic behavior in boys with FXS. This is
accomplished by evaluating multiple indicators of social
approach and cortisol and their inter-relationship over time
in boys with FXS (with and without ASD), compared to a
community sample of typically developing boys. We have
applied a set of three analyses that focus on different
components of the relationship of environmental and
neuroendocrine predictors of ASD in boys with FXS
compared to a typically-developing group of boys. The
first analysis examines multiple dimensions of social
approach behaviors and how they vary over time. The
second analysis investigates mean levels and modulation of
salivary cortisol levels in response to social interaction. The
third analysis examines the relationship of social approach
and autistic behaviors to salivary cortisol. Data for these
analyses were drawn from multiple independent, yet
related, studies of development in FXS that used a common
set of measures across participants. Combining data across
multiple studies increased the sample size, allowing for
more confidence in the findings.
We hypothesize that boys with FXS + ASD will be
distinguished from boys with FXS-only (without ASD) and
the typically developing group by their chronic social
avoidance, elevated cortisol, and strong relationship be-
tween autistic behaviors and cortisol.
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Participants
Data for these analyses were drawn from the Carolina
Fragile X Project, a series of longitudinal studies that
recruited children across the United States through a
F X Sp a r e n tl i s ts e r v e ,aU n i v ersity of North Carolina
(UNC) Fragile X research registry, FXS family support
groups, and brochures sent to FXS clinics and research
projects. All males with FXS had the FMR1 full
mutation based on standard DNA testing. Females were
excluded due to statistical power considerations and
limited control group matches. Descriptive information
including gender, age and adaptive behavior was available
for all participants. Groups were gender matched and age
was included as a co-variate when groups varied on age.
Boys with FXS were subdivided into two groups based on
the level of autistic behavior as detailed below. Table 1
displays a descriptive profile of the three study groups
across the three analyses.
Measures
Autistic behavior
The CARS is a widely used and reliable measure of autistic
behavior in children, with alpha coefficients often at or
exceeding 0.85 [33–36], and a test-retest reliability of 0.88
[37]. The CARS consists of 15 items characteristic of autistic
behavior and a total score. Examiners rate each item between
1 (typical) to 4 (severely abnormal) and the continuum for the
total scores ranges from not autistic (15–29.5), mildly/
moderately autistic (30–36), to severely autistic (≥37). As in
previous studies, the CARS was used to describe autistic
behavior and to categorize participants as either FXS-only
or FXS + ASD, rather than to diagnose autism in FXS [21,
Table 1 Characteristics of the participants across analyses
Analysis Series Participant Groups
Analysis 1: SAS Profiles Typically Developing Group FXS-only FXS + ASD
(n=21) (n=33) (n=18)
(Mean ± SD) (Mean ± SD) (Mean ± SD)
Chronological Age (Years)
bc 4.05±1.95 3.99±2.25 8.13±3.55
Vineland Adaptive Behavior Composite
abc 98.7±10.7 62.7±12.1 41.1±13.3
Childhood Autism Rating Scale Total
c N/A 24.8±3.2 34.0±3.7
Analysis 2: Cortisol (n=63) (n=53) (n=11)
(Mean ± SD) (Mean ± SD) (Mean ± SD)
Chronological Age (Years)
ab 4.88±1.39 7.5±4.06 7.46±4.16
Vineland Adaptive Behavior Composite
abc 98.7±10.7 55.7±16.0 43.5±13.1
Childhood Autism Rating Scale Total
c N/A 24.8±3.1 33.7±3.3
Analysis 3: Behavior Ratings and Cortisol
Cortisol-SAS (n=21) (n=34) (n=9)
(Mean ± SD) (Mean ± SD) (Mean ± SD)
Chronological Age (Years)
bc 4.05±1.95 3.99±2.25 8.13±3.55
Vineland Adaptive Behavior Composite
abc 98.7±10.7 62.7±12.1 41.1±13.3
Childhood Autism Rating Scale Total
c N/A 24.8±3.2 34.0±3.7
Cortisol-CARS (N/A) (n=40) (n=10)
(Mean ± SD) (Mean ± SD) (Mean ± SD)
Chronological Age (Years) N/A 8.03±3.95 7.9±4.1
Vineland Adaptive Behavior Composite
c N/A 55.1±13.5 41.0±13.1
Childhood Autism Rating Scale Total
c N/A 24.6±3.1 32.7±2.0
aSignificant difference between Typically Developing Group and FXS-only
bSignificant difference between Typically Developing Group and FXS + ASD
cSignificant difference between FXS-only and FXS + ASD
J Neurodevelop Disord (2009) 1:283–291 28524, 38]. Children with a score of ≥30 were characterized as
being on the autism spectrum (ASD) and thus classified
as FXS + ASD while those with a score <30 were classified
as FXS-only. Each child was evaluated per administration
guidelines [33], and ratings were based on direct observation,
parent interview, and review of the parent rating scales, after
which, the examiners came to a consensus over the numerical
ratings [8, 21]. CARS scores are not available for the
typically developing group.
Social approach
The Social Approach Scale (SAS) is a time-sensitive
experimental measure of multiple forms of social approach
behavior. As reported, our group modified the original SAS
[39] to include social approach behaviors characteristic of
FXS: physical movement (MO; e.g., walks away), facial
expression (FA; e.g., fearful facial expression), and eye
contact (EC; e.g. avoids eye contact) [24]. Higher scores
reflect more social avoidance.
Over the course of an assessment, examiners assign
scores at multiple time points to compare initial and
sustained social interactions. Data for this study reflect
two time points: “initial” ratings, taken within the first
minute of the assessment, and “familiar” (with the assessor)
ratings, taken in the last hour of the assessment. The
average elapsed time between the initial and regulation
SAS ratings was 3 h (x=3.00; s.d. = .98). Two examiners
were present for each assessment with one primarily
responsible for assessing the child and the other primarily
responsible for logistics and interactions with the child and
mother. Thus, each examiner experienced different types of
interactions with the children and for varied amounts of
time. The SAS was therefore rated by a consensus across
the two examiners to take these factors into account [24].
In our previous work using the SAS, we identified
relationships between social approach, social withdrawal,
and autistic features and established the SAS as a sensitive
and, in this way, valid measure of social approach
behaviors in children with FXS [24].
Cortisol
To study potential HPA-axis abnormalities in FXS and its
relationship with social approach behavior, two samples of
salivary cortisol were taken for each participant. The first
cortisol level, labeled “baseline cortisol”, was taken within
15 min of the onset of the assessment to reflect pre-
evaluation cortisol levels. The second cortisol level, which
we refer to as “regulation cortisol”, was taken at the end of
the SAS evaluation. In addition, we calculated a difference
score based on the change in cortisol (regulation cortisol
minus baseline cortisol), which we refer to as “delta
cortisol”. This measurement is meant to serve as an index
of cortisol reactivity and to aid in the interpretation of the
participants’ physiological response to the social challenge.
Recent findings have linked lower cortisol reactivity to
autistic behavior in FXS so we were interested in
examining these relationships in our sample [27].
The cortisol sample was taken via an oral cotton swab,
which soaked in the participant’s mouth for 1–2 min. To
prevent contamination of saliva samples, participants were
asked to avoid consumption of products containing citric
acid and dairy products for at least 60 min prior to sampling
[40, 41]. The precise time of cortisol collection was
recorded to account for the diurnal variation in cortisol
levels. The saliva was processed using the Salimetrics’
Salivary Cortisol Enzyme Immunoassay kit (EIA). The
correlation between serum and saliva cortisol using the
Salimetrics EIA is highly significant (r=0.91, p<0.0001)
(Salimetrics LLC, 2005). The mean inter-assay coefficient
of variation was 7.70% (5.40%–8.11%) and the mean intra-
assay coefficient of variation was 7.16% (6.88%–7.12%).
Each sample was assayed in duplicate, and duplicate
correlations were >.95. Cortisol levels were measures in
micrograms/deciliter.
Adaptive behavior
The Vineland Adaptive Behavior Scale (VABS) is widely
used to measure adaptive behavior skills of individuals
from birth to 90 years of age [42]. The Adaptive Behavior
Composite (ABC), which integrates VABS’ four domains,
was calculated based on an interview with the parent(s) of
the participant. The VABS has acceptable content and
criterion-related validity and a test-retest reliability of
r=0.88. In our study, we used the VABS as a descriptive
measure of overall adaptive ability for the FXS and typical
cohorts.
Data analysis
The primary goal of this study is to examine environmental
and neuroendocrine determinants of autistic behavior in
young boys with FXS. To accomplish this, we conducted a
series of analyses of covariance (ANCOVA) to examine
SAS scale scores (i.e., physical movement, facial expres-
sion, and eye contact) at initial and familiar assessment
intervals as predicted by group while controlling for age.
We followed up with a regression of CARS total score as a
continuous variable within the group with FXS. Next, we
ran ANCOVAs to examine cortisol levels at initial and
regulation assessment intervals as predicted by group and
age and followed these with a regression of CARS total
score within the group with FXS. Finally, cortisol levels
286 J Neurodevelop Disord (2009) 1:283–291and their correlations with SAS scale scores (for all 3
groups) and CARS total scores (for the 2 groups with FXS)
were analyzed using multiple regression models with age
controlled for. Adaptive behavior was also used as a co-
variate in most models. Stringent post-hoc analyses were
run in order to minimize the effects of variance heteroge-
neity, non-Gaussian distribution, and unequal N values
[43]. The cortisol data were skewed so they were trans-
formed by taking the log10 of the raw data to make it more
amenable to comparative analyses. Hierarchical Bonferroni
corrections were used for adjusting for multiple compar-
isons. Data reported in the Results section has been co-
varied and/or corrected, unless otherwise specified.
Results
SAS profiles
ANCOVA results indicate that the typically developing
group had more approaching physical movement, facial
expression, and eye contact than both groups of boys with
FXS (with and without ASD) for both initial and familiar
social interactions with the exception of physical approach
during familiar interactions that was not different from boys
with FXS-only (see Fig. 1 and Table 2). Interestingly, the
initial social approach of the two groups of boys with FXS
was indistinguishable across all three SAS scales; however,
the boys with FXS + ASD showed less social approach
than boys with FXS without ASD during social interactions
with familiar individuals across all three SAS scales.
Regression analyses of SAS measures versus CARS total
score within the FXS group (not separated for ASD)
supported the ANCOVA findings with no relationship
between CARS and initial SAS scales; yet, a strong
relationship between all three familiar SAS scales and
CARS total score (p≤.005). The relationship between
CARS and familiar physical movement was also significant
for the FXS + ASD subgroup (p<0.05).
Cortisol
ANCOVA results show that both baseline (pre-assessment)
and regulation (post-assessment) cortisol were higher in boys
with FXS + ASD compared to both typically developing boys
a n db o y sw i t hF X Sw i t h o u ta u t i s m, which were not different
from each other (see Fig. 2). There were no differences in
delta (change) cortisol among any of the three groups.
Behavior ratings and cortisol
SAS and Cortisol. Multiple regression analysis results
demonstrate that initial social approach (facial expression
and eye contact) had a significant direct relationship to
regulation and delta cortisol, while familiar social approach
(facial expression and eye contact) had a direct relationship
to baseline cortisol in the typically developing group (see
Table 3). There was also a significant inverse relationship
between initial physical movement and regulation cortisol
in the FXS + ASD group (p=0.028).
CARS and Cortisol. The relationship between the CARS
and cortisol was examined in the entire group of boys with
FXS (not separated for ASD) then in the two groups with
FXS (with and without ASD). Regression analyses of
cortisol to CARS total score within the entire FXS group
revealed no relationship of CARS to cortisol. In contrast, a
multiple regression analysis demonstrated an inverse
relationship between CARS scores and delta cortisol in
the FXS + ASD group (p=0.008). No relationship between
Fig. 1 SAS profiles in FXS. The two FXS groups, FXS-only and
FXS + ASD, showed in general less approach than controls in both
initial and familiar social encounters. However, only the FXS + ASD
group differentiated from FXS-only and the typically developing
group in all three scales during familiar social interactions (i.e.,
persistence of avoidant behaviors)
J Neurodevelop Disord (2009) 1:283–291 287the CARS score and any of the other cortisol measures in
the boys with FXS-only was found. These analyses were
only conducted with the boys with FXS as the CARS was
not available for the typically developing group
Discussion
The primary goal of this study was to examine environ-
mental and neuroendocrine factors that convey increased
risk for elevated autistic behavior in boys with FXS.
Towards this end, we employed a dynamic multi-
dimensional observational scale of social approach behav-
ior and scales of autistic behavior in boys with FXS with
and without severe autistic behavior (FXS + ASD vs. FXS-
only), who were compared to typically developing boys. In
addition, we included levels of salivary cortisol before and
after the assessment as a potential biomarker for ASD-
related behaviors. Identifying risk factors for autism in FXS
is critical to refine the phenotype, contribute to improved
diagnostic specificity of autism in FXS, and identify
potential preventive or treatment options.
Our study indicates distinct social approach profiles on
the SAS that uniquely differentiated typically developing
boys from the FXS-only and FXS + ASD groups, and
uniquely differentiated ASD behaviors across the two FXS
groups. All three groups displayed the same trend of
increased social approach with increased familiarity over
time across the physical movement, facial expression, and
eye contact scales. However, both groups of boys with FXS
demonstrated elevated levels of social avoidance for facial
expression and eye contact across initial and familiar
encounters compared to the typically developing group.
Avoidant physical movement appeared more complex and
actually differentiated among the three groups over time.
Specifically, both groups of boys with FXS were more
avoidant than typically developing boys during initial
encounters; however, only boys with FXS + ASD contin-
ued to be physically avoidant during familiar encounters,
which differentiated them from both the typically develop-
ing group and FXS-only. Furthermore, correlations between
CARS total scores as a continuum versus SAS measures in
the entire FXS group revealed that autistic behavior was
significantly related to a persistence of avoidant approach
behavior. Consistent with our previous work [24], these
findings indicate that the SAS is sensitive to identify both
the pervasive social abnormalities that distinguish boys
with FXS from typically developing peers, in general, and
to differentiate boys with FXS with and without ASD. This
Fig. 2 Cortisol profiles in FXS. As depicted in these log transformed
graph bars, the FXS + ASD group had significantly higher baseline
and regulation cortisol levels than the FXS-only and control groups
(*p<0.05). Although the FXS-only group had higher delta values,
these differences were not significant
Table 2 SAS Profile ANCOVA Results
Typically Developing Group Typically Developing Group FXS-only
vs. vs. vs.
FXS-only FXS + ASD FXS + ASD
(p-value, F-value) (p-value, F-value) (p-value, F-value)
Initial Approach
Physical Movement p=0.0012, F=11.987 p<0.0001, F=12.590 p=0.1929, F=0.371
Facial Expression p=0.0008, F=12.792 p<0.0001, F=26.616 p=0.1583, F=1.563
Eye Contact p<0.0001, F=24.122 p<0.0001, F=62.756 p=0.1285, F=1.612
Familiar Approach
Physical Movement p=0.5093, F=0.472 p=0.0003, F=1.969 p=0.0002, F=2.867
Facial Expression p=0.0018, F=10.808 p<0.0001, F=22.628 p=0.0019, F=8.935
Eye Contact p=0.0005, F=13.982 p<0.0001, F=54.041 p<0.0001, F=12.060
Age was used as a co-variate in all analyses due to the fact that the FXS + ASD group was substantially older than both the typically developing
group and FXS-only group
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specific time-sensitive dynamic social behaviors to consider
when making differential diagnoses of autism in FXS and
when developing treatments. The recognition that persistent
social avoidance can differentiate children with FXS with
autism from those who exhibit only initial social avoidance
and do not have autism suggests that clinicians need to
gather this information and treatment plans should be
targeted to the pattern of social avoidance displayed by
the child.
Consistent with the SAS profiles, cortisol analyses
indicate a unique neuroendocrine profile for the boys with
FXS + ASD. Boys with FXS + ASD had elevated baseline
and regulation levels compared to both typicals and boys
with FXS who were not different from each other. In
contrast, delta (change) cortisol levels were not different
among any of the groups. These findings are consistent
with previous reports of elevated pre-assessment cortisol
[27, 31] and similar cortisol change scores [27] in boys
with FXS compared to typical siblings. However, our
findings are unique in that we report cortisol abnormalities
specific only to the FXS + ASD group whereas existing
work does not differentiate between groups with FXS alone
and those with FXS + ASD.
Integration of cortisol and behavior indicates that
typically developing boys show strong relationships be-
tween cortisol and social approach on the SAS, with initial
approach strongly correlated with cortisol reactivity and
familiar approach with baseline cortisol levels, profiles that
are consistent with existing literature on the general
population [44–46]. In contrast, cortisol and SAS measures
are weakly associated in the FXS + ASD group, only in
terms of initial approach, and no relationship is found in the
FXS-only group. Consistent with previous work [27],
increased autistic behavior on the CARS is inversely
correlated with change in cortisol (i.e., delta cortisol) in
the group with FXS + ASD that contrasted with no
relationship in the FXS-only group. The blunted cortisol
regulation in boys with FXS + ASD is most likely related to
their elevated baseline levels, which limits the range of
cortisol reactivity. Nonetheless, it is interesting to note that
the relationship with CARS scores was limited to the delta/
change score and not to the elevated baseline or regulation
levels given that group differences existed for the baseline
and regulation scores and not the delta/change scores.
Considering that the FXS + ASD group has already
relatively elevated CARS scores, this intriguing result also
suggests that there is a behavioral threshold for the
relationship between autistic behavior and cortisol.
Our data showing that elevated cortisol and a relation-
ship between CARS scores and cortisol was unique to the
group with FXS + ASD, and not present in the FXS-only
group, suggest that HPA dysfunction may be a biomarker
for ASD in boys with FXS. HPA axis dysfunction as a
biomarker for autism in FXS is partially supported by
evidence from existing studies that indicate a relationship
between elevated pre-assessment cortisol and increased
autistic behaviors including gaze avoidance and poor eye
contact in boys with FXS [19, 27]. However, these studies
did not differentiate autism status within the group of boys
with FXS so it is not clear if the relationship between
cortisol and autism is pervasive across all boys with FXS or
unique to those with elevated autistic behavior as we found
in our study. Also, our study included a younger sample
than reported in existing work (mean age 7.5 years
compared to 10.8, 13.1, and 13.5; 19, 27, 30, 31), which
extends the application of this biomarker to children in
early to middle childhood. Given the strong evidence of
cortisol stability across childhood [47–51], we do not
believe our findings reflect blunted cortisol responses in
young children, or in response to chronic stress, but further
demonstrate that cortisol is a marker of autism in FXS. In
contrast to our findings and existing work, a recent study
reported a relationship between elevated pre-assessment
Table 3 Cortisol levels vs. measures of the SAS and CARS total score
Baseline Regulation Delta
Cortisol Cortisol Cortisol
Initial Approach Physical Movement – 0.0284
b
Facial Expression – 0.0009
a 0.0092
a
Eye Contact – 0.0155
a 0.0456
a
Familiar Approach Physical Movement –– –
Facial Expression 0.0032
a ––
Eye Contact 0.0032
a ––
CARS Total Score –– 0.0077
b
aSignificant direct relationship in typically developing group
bSignificant inverse relationship in FXS + ASD group
J Neurodevelop Disord (2009) 1:283–291 289cortisol and lowered autistic behavior on the ADOS-G in
FXS [19]. Nevertheless, this study did not examine
regulation levels or changes in cortisol in relation to autistic
behavior and defined the pre-assessment phase as the
interval preceding the administration of the ADOS-G,
which occurred mid-day after approximately 5 h of
assessment and interaction [19], making direct comparisons
across studies difficult.
Taken together, our work and others indicate a relation-
ship between HPA function and autistic behavior in boys
with FXS that is complex and interactive with environ-
mental factors, including time spent in social interaction
and the format and intensity of stressful events. Given that
HPA dysfunction has also been implicated in idiopathic
autism as reflected in abnormal baseline levels and
circadian profiles [52–54] and exaggerated cortisol reactiv-
ity to social stresses in young children with ASD [53, 55–
57], future studies including samples of children with FXS
with and without ASD, as well as with idiopathic autism,
would be highly informative about HPA axis function and
its relationship with autistic behavior. The latter research
should not only address the seemingly contradictory
idiopathic ASD [52, 53, 58] and FXS literature [19, 27,
31] on cortisol levels and regulation, but also to advance
our understanding of the causal relationship between
cortisol (i.e., correlate or modifier) and autistic behavior.
The present study should be considered as a preliminary
examination of the relationship between environmental and
neuroendocrine factors and autistic behavior in FXS.
Although our design included several strengths, such as
the dynamic assessment of social approach behaviors by the
SAS and cortisol measurements in the context of the SAS,
there were also some shortcomings. The latter included the
use of CARS and not the most contemporary ADI-R and
ADOS-G for evaluating autistic behaviors, absence of
measures of social anxiety, and variable and limited sample
sizes for the different analyses. Additional cortisol measure-
ments throughout a series of social interactions would
have also been informative about the dynamics of cortisol
regulation, as well as other indices of the HPA axis (e.g.,
ACTH). Certainly prospective, longitudinal studies that
measure multiple factors including behavior, learning,
gene and brain function, and environmental stressors in
samples of individuals with FXS, typically developing
children and relevant clinical groups such as idiopathic
autism would be necessary to further delineate the role of
environmental and neuroendocrine factors in autistic
behavior in FXS.
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